|Bid||0.00 x 1000|
|Ask||10.38 x 3200|
|Day's range||9.68 - 10.02|
|52-week range||2.72 - 12.04|
|Beta (5Y monthly)||0.49|
|PE ratio (TTM)||N/A|
|Earnings date||08 May 2023 - 12 May 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||11.95|
SAN FRANCISCO, March 16, 2023--Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, is adding five new members to its Medical Advisory Board. The group of specialists advises the company as it works to create access to safe, high-quality, personalized care and treatment. These new advisors represent a diverse group of medical experts specializing in medicine related to obesity, menopause, and cardiometabolic health.
SAN FRANCISCO, March 15, 2023--Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, is today announcing Hims Dandruff Detox, a unique shampoo formulated with doctors that both fights dandruff and supports scalp health. This powerful and gently-cleansing formula was developed with doctors to be vegan, cruelty-free and free of parabens, phthalates, sulfates and dyes.
SAN FRANCISCO, March 14, 2023--Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform on a mission to help the world feel great through the power of better health, today announces a key leadership appointment, naming psychiatry and behavioral sciences industry veteran Dr. Daniel Lieberman, M.D., as the company’s Senior Vice President of Mental Health.